These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 25446182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DJ-1 protects against cell death following acute cardiac ischemia-reperfusion injury.
    Dongworth RK, Mukherjee UA, Hall AR, Astin R, Ong SB, Yao Z, Dyson A, Szabadkai G, Davidson SM, Yellon DM, Hausenloy DJ.
    Cell Death Dis; 2014 Feb 27; 5(2):e1082. PubMed ID: 24577080
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
    Ong SG, Lee WH, Theodorou L, Kodo K, Lim SY, Shukla DH, Briston T, Kiriakidis S, Ashcroft M, Davidson SM, Maxwell PH, Yellon DM, Hausenloy DJ.
    Cardiovasc Res; 2014 Oct 01; 104(1):24-36. PubMed ID: 25063991
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent.
    Hausenloy DJ, Boston-Griffiths EA, Yellon DM.
    Br J Pharmacol; 2012 Mar 01; 165(5):1235-45. PubMed ID: 21955136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.
    Hausenloy DJ, Ong SB, Yellon DM.
    Basic Res Cardiol; 2009 Mar 01; 104(2):189-202. PubMed ID: 19242644
    [Abstract] [Full Text] [Related]

  • 13. Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Li X, Jia P, Huang Z, Liu S, Miao J, Guo Y, Wu N, Jia D.
    Drug Des Devel Ther; 2019 Mar 01; 13():2331-2342. PubMed ID: 31371925
    [Abstract] [Full Text] [Related]

  • 14. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury.
    Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A.
    Pharmacol Res; 2022 Jan 01; 175():105986. PubMed ID: 34800627
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.
    Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R.
    Basic Res Cardiol; 2010 Nov 01; 105(6):771-85. PubMed ID: 20960209
    [Abstract] [Full Text] [Related]

  • 16. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A.
    Kardiol Pol; 2011 Nov 01; 69 Suppl 3():59-66. PubMed ID: 22125205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM.
    Cardiovasc Res; 2002 Aug 15; 55(3):534-43. PubMed ID: 12160950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.